BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15928309)

  • 1. Rescuing COX-2 inhibitors from the waste bin.
    Albini A; Noonan DM
    J Natl Cancer Inst; 2005 Jun; 97(11):859-60. PubMed ID: 15928309
    [No Abstract]   [Full Text] [Related]  

  • 2. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
    Harv Heart Lett; 2006 Oct; 17(2):1-3. PubMed ID: 17153752
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular toxicity of valdecoxib.
    Ray WA; Griffin MR; Stein CM
    N Engl J Med; 2004 Dec; 351(26):2767. PubMed ID: 15608086
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 5. Does celecoxib use increase the risk of cardiovascular events?
    Oviedo JA; Schroy PC
    Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract]   [Full Text] [Related]  

  • 7. Arthritis medicines and cardiovascular events--"house of coxibs".
    Topol EJ
    JAMA; 2005 Jan; 293(3):366-8. PubMed ID: 15623849
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
    Messerli FH; Sichrovsky T
    Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
    [No Abstract]   [Full Text] [Related]  

  • 9. Celebrex: new ad, with questionable claims.
    Consum Rep; 2007 Aug; 72(8):52-3. PubMed ID: 17644835
    [No Abstract]   [Full Text] [Related]  

  • 10. New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.
    Dubois RN
    Cancer Prev Res (Phila); 2009 Apr; 2(4):285-7. PubMed ID: 19336723
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
    Jugdutt BI
    Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
    Meyer CH
    Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404
    [No Abstract]   [Full Text] [Related]  

  • 13. Coxibs and cardiovascular risk.
    Allen MJ; McLean-Veysey P; Fleming I
    CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
    [No Abstract]   [Full Text] [Related]  

  • 14. Celecoxib shown effective in preventing colon polyps.
    Nelson NJ
    J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy with COX-2 inhibitors. Less risk--better tolerance].
    MMW Fortschr Med; 2000 Dec; 142(49-50):65-6. PubMed ID: 11190944
    [No Abstract]   [Full Text] [Related]  

  • 16. More pain for painkillers.
    Sifferlin A
    Time; 2013 Jun; 181(24):14. PubMed ID: 24044255
    [No Abstract]   [Full Text] [Related]  

  • 17. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 18. The COX-2 inhibitors--an update.
    Furberg CD
    Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
    [No Abstract]   [Full Text] [Related]  

  • 19. Painful lessons.
    Nat Struct Mol Biol; 2005 Mar; 12(3):205. PubMed ID: 15744317
    [No Abstract]   [Full Text] [Related]  

  • 20. Pfizer: Celebrex increases heart attack risk.
    Health News; 2005 Feb; 11(2):2. PubMed ID: 15732142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.